Top 10 digital health deals of Q3

While digital health funding dropped by nearly one-third in the third quarter of 2022, there were still notable deals for health tech companies.

Advertisement

Here are the top 10 equity deals by dollar amount, according to an Oct. 11 CB Insights report:

1. Dami & Xiaomi (China): $420 million

2. ArsenalBio (U.S.): $220 million

3. Cleerly (U.S.): $192 million

4. Allm (Japan): $182 million

5. Cera (U.K.): $160 million

6. WeDoctor (China): $150 million

7. Alma (U.S.): $130 million

8. Senda Biosciences (U.S.): $123 million

9. Fortanix (U.S.): $90 million

10. Incredible Health (U.S.): $80 million

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Digital Health

Advertisement

Comments are closed.